Business / Finance

RSS

NAMSA announces acquisition of Medvance

NAMSA, the world's leading medical research organization, is pleased to announce the acquisition of Medvance Ltd., a clinical research and resourcing organization located in Yorkshire, England.

10 Jan 2014

Akorn acquires NDA and all rights to Betimol from Santen

Akorn, Inc., a niche generic pharmaceutical company, today announced that it has acquired the NDA and all rights to Betimol (timolol ophthalmic solution) 0.25% & 0.5% from Santen. Akorn plans to begin shipping Betimol in the first quarter of 2014.

9 Jan 2014

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Biogen Idec and Sangamo BioSciences, Inc. announced today an exclusive worldwide collaboration and license agreement focused on the development of therapeutics for hemoglobinopathies, inherited conditions that result from the abnormal structure or underproduction of hemoglobin.

9 Jan 2014

Zymeworks, ImClone Systems partner to develop novel bi-specific antibody oncology therapeutics

Zymeworks Inc. today announced that it has entered into a licensing and collaboration agreement with ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, to develop an undisclosed number of novel bi-specific antibody oncology therapeutics using Zymeworks' proprietary Azymetric platform. Bi-specific antibodies have the potential to provide improved outcomes for patients by simultaneously targeting two tumor associated antigens to induce a synergistic therapeutic response.

9 Jan 2014

Illumina signs multi-year licensing agreement with Quest Diagnostics

Illumina, Inc. today announced it has entered into a multi-year licensing agreement with Quest Diagnostics, the world's leading provider of diagnostic information services, related to the use of Illumina's next-generation sequencing technology for clinical laboratory testing.

From Illumina, Inc. 9 Jan 2014

MicroPort Scientific, Sorin Group form joint venture to market CRM devices in China

MicroPort Scientific Corporation and Sorin Group, announced today that they have entered into a definitive agreement to form a joint venture to market and develop cardiac rhythm management devices (implantable pacemakers, defibrillators, cardiac resynchronization devices and related devices) in China. MicroPort will hold a 51 percent stake in the joint venture entity, while Sorin will hold the remaining 49 percent interest.

9 Jan 2014

Evolva to set up Level-1 American Depositary Receipt programme

Evolva Holding SA has appointed BNY Mellon, the global leader in investment management and investment services, to set up a Level-1 American Depositary Receipt programme.

9 Jan 2014

ILiAD, Inserm and IPL sign worldwide license agreement for Bordetella pertussis vaccine technology

ILiAD Biotechnologies, LLC, the French National Institute of Health and Medical Research subsidiary, Inserm Transfert SA, and Institut Pasteur de Lille today announced the signing of scientific collaboration and worldwide license agreements for live attenuated Bordetella pertussis vaccine technology, including BPZE1, developed by the laboratory of Professor Camille Locht. This license agreement covers patent rights from Institut Pasteur de Lille, Inserm, National University of Singapore and National University of Ireland Maynooth.

9 Jan 2014

Globus Medical acquires Excelsius Surgical

Globus Medical, Inc., a leading musculoskeletal implant manufacturer, today announced that it has acquired Excelsius Surgical. Excelsius Surgical is developing a next generation surgical robotic positioning platform for spine, brain and therapeutic markets.

9 Jan 2014

AccentHealth buys Caervision's Asthma and Allergy waiting room television network

AccentHealth, the leading patient education company at the Point-of-Care, announced today it has purchased the Asthma and Allergy waiting room television network of Caervision Corp. The new doctor office locations will become part of the AccentHealth network and will carry AccentHealth's award-winning health education programming produced by CNN.

9 Jan 2014

Forest Laboratories enters into definitive agreement to acquire Aptalis

Forest Laboratories, Inc. today announced that it has entered into a definitive agreement to acquire Aptalis, a privately held U.S. based specialty Gastrointestinal and Cystic Fibrosis company, for $2.9 billion in cash from its shareholders, including TPG, the global private investment firm. The acquisition, which requires review by anti-trust authorities in the US and Canada, is expected to be accretive to Forest's FY2015 non-GAAP EPS.

8 Jan 2014

Duke LifePoint Healthcare, Wilson Medical Center sign definitive agreement to form joint venture

The Wilson Medical Center Board of Directors has taken the next step in becoming part of Duke LifePoint Healthcare. The organizations have signed a definitive agreement to form a joint venture. The proposed joint venture, which will provide Wilson Medical Center with resources to enhance its services and invest in its growth, is moving forward following a positive vote by the Wilson County Board of Commissioners. The agreement is under review by the Attorney General of North Carolina.

8 Jan 2014

UMF Medical receives Amerinet Choice Contract award

UMF Medical, trusted manufacturer of Complete Exam Room Equipment Solutions, today announces its Amerinet Choice Contract award.

8 Jan 2014

Carl Zeiss Meditec acquires 100% of shares in Aaren Scientific

Carl Zeiss Meditec AG announces it has acquired, through its subsidiary Carl Zeiss Meditec Inc., 100% of the shares in Aaren Scientific Inc., a US-based manufacturer of intraocular lenses (IOLs). Aaren Scientific, headquartered in Ontario, California, has been manufacturing IOLs for more than two decades. The majority of shares in Aaren Scientific had previously been owned by a private investment company as well as other investors, including the CEO and co-founder of Aaren Scientific, Rick Aguilera, who along with the entire management team will stay on board after the transaction.

8 Jan 2014

ArthroCare enters into Deferred Prosecution Agreement with the U.S. Department of Justice

ArthroCare Corp., a leader in developing state-of-the-art, minimally invasive surgical products, and the U.S. Department of Justice entered into a Deferred Prosecution Agreement filed today with the United States District Court in the Western District of Texas (the Court).

8 Jan 2014

Qardio launches revolutionary blood pressure monitor at 2014 CES show

Qardio, a technology company dedicated to transforming the way we manage our heart health and track our wellness, is formally announcing the launch of the QardioArm at the 2014 CES show. QardioArm is a revolutionary blood pressure monitor.

8 Jan 2014

A&D Medical to partner with Salutron to expand Wellness Connected platform

In a strategic business decision to provide its customers with an optimized connected health experience, A&D Medical, a global manufacturer of precision measurement solutions for the healthcare industry, announced today it will partner with Salutron, the industry leader in wearable activity monitoring technology with heart rate. With this alliance, A&D Medical will include Salutron's LifeTrak family of Bluetooth Smart activity monitors as a core component of its new Wellness Connected Platform and device suite.

8 Jan 2014

JDRF joins with Brehm Center to investigate about lost beta cell function in type 1 diabetes

JDRF announced today the funding of an approximately $1 million collaboration with the University of Michigan's Brehm Center and the Brehm Coalition to evaluate a new hypothesis on why beta cells lose their ability to produce insulin, resulting in a diagnosis of type 1 diabetes (T1D).

8 Jan 2014

CROS NT acquires MDSL International

As part of the CROS NT Group global growth strategy, CROS NT Ltd today announced the acquisition of MDSL International - a specialist clinical Contract Research Organization (CRO) providing biometrics services such as Clinical Data Management and Statistical services. The financial details of the transaction remain confidential.

8 Jan 2014

Applied BioCode signs License and Supply Agreement with Genetic Analysis for BMB technology

Applied BioCode announced today that it has signed a License and Supply Agreement for its Barcoded Magnetic Bead technology with Genetic Analysis of Oslo, Norway.

7 Jan 2014

Business / Finance

NAMSA announces acquisition of Medvance

Akorn acquires NDA and all rights to Betimol from Santen

Biogen Idec, Sangamo BioSciences partner to develop therapeutics for hemoglobinopathies

Zymeworks, ImClone Systems partner to develop novel bi-specific antibody oncology therapeutics

Illumina signs multi-year licensing agreement with Quest Diagnostics

MicroPort Scientific, Sorin Group form joint venture to market CRM devices in China

Evolva to set up Level-1 American Depositary Receipt programme

ILiAD, Inserm and IPL sign worldwide license agreement for Bordetella pertussis vaccine technology

Globus Medical acquires Excelsius Surgical

AccentHealth buys Caervision's Asthma and Allergy waiting room television network

Forest Laboratories enters into definitive agreement to acquire Aptalis

Duke LifePoint Healthcare, Wilson Medical Center sign definitive agreement to form joint venture

UMF Medical receives Amerinet Choice Contract award

Carl Zeiss Meditec acquires 100% of shares in Aaren Scientific

ArthroCare enters into Deferred Prosecution Agreement with the U.S. Department of Justice

Qardio launches revolutionary blood pressure monitor at 2014 CES show

A&D Medical to partner with Salutron to expand Wellness Connected platform

JDRF joins with Brehm Center to investigate about lost beta cell function in type 1 diabetes

CROS NT acquires MDSL International

Applied BioCode signs License and Supply Agreement with Genetic Analysis for BMB technology

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News